Holen Sie sich die Stockscreener-App
1.74
0.28%
0.02
Schlusskurs vom Vortag:
$1.76
Offen:
$1.74
24-Stunden-Volumen:
1,644
Relative Volume:
0.00
Marktkapitalisierung:
$4.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.85M
KGV:
-0.1078
EPS:
-16.1435
Netto-Cashflow:
$-15.72M
1W Leistung:
+0.28%
1M Leistung:
-14.44%
6M Leistung:
-49.43%
1J Leistung:
+179.01%
1-Tages-Spanne:
$1.74
$1.8099
1-Wochen-Bereich:
$1.62
$1.8099
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Compare INDP vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
1.8099 | 3.95M | 0 | -20.85M | -15.72M | -16.14 |
VRTX
Vertex Pharmaceuticals Inc
|
455.52 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.92 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
331.11 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.44 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.46 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Insider Buyers Lose US$40k As Indaptus Therapeutics Sheds US$583k - simplywall.st
Indaptus Therapeutics, Inc. Files Form 8-K Reporting Changes in Control – Key SEC Filing Details 3 - Minichart
Indaptus Therapeutics (INDP) shifts control and names Junyi Dai CEO-Chair - Stock Titan
Lazar cuts Indaptus (NASDAQ: INDP) preferred stake, resigns as co‑CEO but stays on board - Stock Titan
Indaptus (INDP) director exits Series AAA stake, trims Series AA - Stock Titan
Short Covering: Does Indaptus Therapeutics Inc have declining or rising EPS2026 Major Catalysts & Safe Entry Zone Identification - baoquankhu1.vn
Market Outlook: Does Indaptus Therapeutics Inc have declining or rising EPSPortfolio Performance Report & Trade Opportunity Analysis Reports - baoquankhu1.vn
Indaptus Therapeutics, Inc. 2025 Annual Report: Company Overview, Risks, Investment Transaction, and Regulatory Compliance - Minichart
Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Lazar-backed Indaptus Therapeutics (NASDAQ: INDP) halts trials, eyes strategic deal - Stock Titan
CEO Change: Will PANL stock hit new highs in YEAR2026 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Published on: 2026-03-17 18:45:40 - baoquankhu1.vn
INDPIndaptus Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Indaptus Therapeutics (INDP) Stock Analysis Report | Financials & Insights - Benzinga Japan
Why Indaptus Therapeutics Inc. stock remains on buy listsWeekly Stock Report & Safe Entry Momentum Tips - Naître et grandir
Will Indaptus Therapeutics Inc. stock keep outperforming rivalsWeekly Trade Summary & Safe Entry Zone Identification - Naître et grandir
Indaptus Therapeutics Inc expected to post a loss of $4.36 a shareEarnings Preview - TradingView
Does Indaptus Therapeutics Inc. have declining or rising EPSPortfolio Profit Report & Daily Stock Momentum Reports - Mfd.ru
Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday - Defense World
CapEx per share of Indaptus Therapeutics, Inc. – NASDAQ:INDP - TradingView
Lazar takes 98% control stake in Indaptus Therapeutics (INDP) via $6M deal - Stock Titan
Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement - marketscreener.com
Indaptus Shareholders Approve Major Charter and Capital Changes - The Globe and Mail
Indaptus Therapeutics shareholders approve preferred stock conversion and company charter amendments - Investing.com
Indaptus (INDP) director Jerome Jabbour awarded options on 25,000 shares - Stock Titan
Indaptus Therapeutics (NASDAQ: INDP) investors back control shift, share boost - Stock Titan
Indaptus Therapeutics (INDP) director Jerome Jabbour files initial Form 3 - Stock Titan
Rate Hike: Why is Indaptus Therapeutics Inc stock going up2025 Trading Recap & Weekly Stock Performance Updates - baoquankhu1.vn
Indaptus Therapeutics (INDP) director discloses holding 25,000 common shares - Stock Titan
INDP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volume Summary: Can Champion Homes Inc reach resistance levels soonGap Up & Verified Swing Trading Watchlist - baoquankhu1.vn
INDP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Does Indaptus Therapeutics Inc. have a sustainable dividend2025 Technical Overview & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Can Indaptus Therapeutics Inc. stock reach $100 price target2025 Support & Resistance & Accurate Buy Signal Notifications - mfd.ru
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support - TipRanks
Indaptus Therapeutics Signs Multiple Material Agreements - TradingView
What’s the analyst consensus on Indaptus Therapeutics Inc.Market Volume Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is Indaptus Therapeutics Inc. stock undervalued right nowJuly 2025 Review & Risk Managed Trade Strategies - mfd.ru
How Indaptus Therapeutics Inc. stock benefits from strong dollarMarket Rally & Real-Time Volume Trigger Notifications - mfd.ru
Published on: 2026-02-04 21:21:37 - baoquankhu1.vn
INDP Price Today: Indaptus Therapeutics, Inc. Stock Price, Quote & Chart - mexc.co
Is Indaptus Therapeutics Inc.’s ROE strong enough2025 Top Decliners & Target Return Focused Picks - mfd.ru
Retail Trends: Why is Indaptus Therapeutics Inc stock going down2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn
Update Recap: Whats next for Indaptus Therapeutics Inc stock2025 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Insider Trends: Why is Indaptus Therapeutics Inc stock going up2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation - Investing.com India
Indaptus Therapeutics cuts executive pay, director stays on - TipRanks
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation By Investing.com - Investing.com South Africa
Indaptus Therapeutics Announces Board Member Decision - TradingView — Track All Markets
Aug Wrap: Is Indaptus Therapeutics Inc stock a buy or sellMarket Risk Summary & AI Driven Price Forecasts - baoquankhu1.vn
MACD Signal: Is Indaptus Therapeutics Inc stock a good pick for beginnersEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):